Examkin

Question

Difficulty: HardGynecologic Oncology

A female patient in her early sixties presents to her primary care provider reporting vaginal spotting that began two weeks ago. She achieved menopause ten years ago and had been entirely asymptomatic since that time. Recently, she has also noted bilateral breast tenderness and a sensation of pelvic fullness. Her past medical history is notable only for well-controlled essential hypertension. Vital signs are within normal limits. On physical examination, her breasts are mildly tender to palpation but lack any discrete nodules, skin changes, or nipple discharge. Bimanual pelvic examination reveals a solid, mobile, palpable left adnexal mass measuring approximately 7 cm in diameter. Pelvic sonography is subsequently performed, confirming a 7.5-cm solid-cystic left ovarian mass and revealing an endometrial stripe thickness of 12 mm. Which of the following is the most appropriate next step in the management of this patient's condition?

  1. Office-based histologic evaluation of the endometriumAnswer
  2. B
    Immediate scheduling for exploratory laparotomy and tumor debulking
  3. C
    Discharge with instructions for a follow-up pelvic sonogram in three months
  4. D
    Initiation of intravenous broad-spectrum antimicrobial therapy
  5. E
    Measurement of serum testosterone and dehydroepiandrosterone sulfate levels

Answer

Office-based histologic evaluation of the endometrium
The patient's presentation of a solid-cystic adnexal mass, postmenopausal bleeding, a thickened endometrial stripe, and breast tenderness is highly suspicious for an estrogen-secreting ovarian neoplasm, most notably an adult granulosa cell tumor. Granulosa cell tumors secrete estradiol, leading to unopposed estrogen exposure. This continuous estrogenic stimulation frequently causes concurrent endometrial hyperplasia or endometrial adenocarcinoma. Therefore, before proceeding to surgical resection of the ovarian mass, an office-based histologic evaluation of the endometrium is the most appropriate next step. Confirming the presence and grade of an underlying endometrial malignancy preoperatively is critical, as it alters the planned surgical approach (e.g., necessitating comprehensive surgical staging including lymphadenectomy rather than just a simple hysterectomy and bilateral salpingo-oophorectomy).

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and imaging findings.
The combination of postmenopausal bleeding, breast tenderness, a thickened endometrial stripe (12 mm), and a complex adnexal mass indicates an estrogen-secreting ovarian neoplasm, most likely an adult granulosa cell tumor.
Granulosa cell tumors are the most common malignant sex cord-stromal tumors and classically present with hyperestrogenism.
2
Evaluate the downstream effects of the suspected pathology.
Unopposed estrogen secretion places the patient at high risk (up to 10%) for concurrent endometrial hyperplasia or adenocarcinoma.
Chronic estrogenic stimulation without progesterone opposition leads to endometrial proliferation and malignant transformation.
3
Determine the most appropriate management sequence.
The endometrium must be sampled histologically before taking the patient to the operating room.
A preoperative diagnosis of endometrial cancer mandates comprehensive surgical staging (e.g., lymph node dissection), which alters the informed consent and surgical plan compared to removing an isolated ovarian mass.

Key Concept

Granulosa cell tumors often secrete high levels of estrogen, leading to a significantly increased risk of concurrent endometrial hyperplasia or adenocarcinoma; therefore, endometrial sampling is required prior to surgical intervention to appropriately plan the surgical staging.
Rate this question

Topics

Gynecologic Oncology

More questions from this topic